2021S0161-1 03/05/21
 
  By: Schwertner, Buckingham S.B. No. 1161
 
 
A BILL TO BE ENTITLED
 
AN ACT
  relating to patient choice in the dispensing of
  clinician-administered drugs.
         BE IT ENACTED BY THE LEGISLATURE OF THE STATE OF TEXAS:
         SECTION 1.  Subchapter A, Chapter 1369, Insurance Code, is
  amended by adding Section 1369.0042 to read as follows:
         Sec. 1369.0042.  PROHIBITION AGAINST LIMITING PATIENT
  CHOICE WITH CLINICIAN-ADMINISTERED DRUGS. (a) In this section:
               (1)  "Administer" means to directly apply a drug to the
  body of a patient by injection, inhalation, ingestion, or any other
  means.
               (2)  "Clinician-administered drug" means an outpatient
  prescription drug other than a vaccine that:
                     (A)  cannot reasonably be self-administered by
  the patient to whom the drug is prescribed or by an individual
  assisting the patient with the self-administration; and
                     (B)  is typically administered:
                           (i)  by a physician or other health care
  provider authorized under the laws of this state to administer the
  drug, including when acting under a physician's delegation and
  supervision; and
                           (ii)  in a physician's office, hospital
  outpatient infusion center, or other clinical setting.
               (3)  "Physician" means an individual licensed to
  practice medicine in this state.
               (4)  "Health care provider" means an individual who is
  licensed, certified, or otherwise authorized to provide health care
  services in this state.
         (b)  An individual or group accident and health insurance
  policy, contract, or agreement governed by the laws of this state
  may not:
               (1)  require clinician-administered drugs to be
  dispensed by a pharmacy selected by the health plan;  
               (2)  if a clinician-administered drug is otherwise
  covered, limit or exclude coverage for such drugs when not
  dispensed by a pharmacy selected by the health plan; 
               (3)  reimburse at a lesser amount
  clinician-administered drugs dispensed by a pharmacy not selected
  by the health plan; or 
               (4)  require that an enrollee covered under such a
  policy, contract, or agreement pay an additional fee, higher copay,
  higher coinsurance, second copay, second coinsurance, or any other
  form of price increase for clinician-administered drugs when not
  dispensed by a pharmacy selected by the health plan.
         (c)  Nothing in this section may be construed as:
               (1)  authorizing a person to administer a drug when
  otherwise prohibited under the laws of this state or federal law; or
               (2)  modifying drug administration requirements under
  the laws of this state, including any requirements related to
  delegation and supervision of drug administration.
         SECTION 2.  This Act takes effect September 1, 2021.